GENMAB AS | 337.20 / -3.52% |
Date/Time | 01/27 / 17:32 |
Chg. / Chg.(%) | -12.30 / -3.52% |
Bid | - |
Ask | - |
Open | 337.20 |
Previous Close | 349.50 |
High | 337.20 |
Low | 337.20 |
Volume [EUR] | - |
Volume [Units] | 0 |
Price fixings | 1 |
ISIN | DK0010272202 |
Security | GMAB |
Exchange | Vienna Global Market |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
OMX Nordic | 2,501.00 | ![]() |
266,456 |
Cboe Europe .. | 2,501.00 | ![]() |
39,805 |
Turquoise | 2,507.00 | ![]() |
11,888 |
London Inter.. | 2,491.0 | ![]() |
5,075 |
Cboe Europe .. | 2,509.50 | ![]() |
818 |
TradeGate | 337.400 | ![]() |
355 |
Nasdaq Other.. | 403.0800 | ![]() |
342 |
Cboe Europe .. | 2,514.00 | ![]() |
129 |
Frankfurt | 337.6000 | ![]() |
102 |
gettex | 335.000 | ![]() |
4 |
Vienna Globa.. | 337.20 | ![]() |
0 |
München | 348.10 | ![]() |
0 |
Düsseldorf | 336.70 | ![]() |
0 |
Berlin | 336.50 | ![]() |
0 |
Stuttgart | 334.600 | ![]() |
0 |
Lang & Schwa.. | 334.90 | ![]() |
|
Mexico | 7,292.62 | ![]() |
111 |
News
- Genmab Announces 2020 Net Sales of DARZALEX® (daratumumab)
01/26/2021 / 12:45 - GlobeNewswire - Genmab Announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis
01/15/2021 / 20:17 - GlobeNewswire - Genmab Achieves USD 40 Million Milestone in Collaboration with AbbVie
01/13/2021 / 15:20 - GlobeNewswire - Genmab Announces Phase 3 Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer
01/04/2021 / 20:00 - GlobeNewswire - Genmab Announces Enapotamab Vedotin Update
11/24/2020 / 16:40 - GlobeNewswire